ID

14105

Beschreibung

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01507311

Link

https://clinicaltrials.gov/show/NCT01507311

Stichworte

  1. 29.03.16 29.03.16 -
Hochgeladen am

29. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT01507311

Eligibility Diabetes NCT01507311

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01507311
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with type 2 diabetes, either newly diagnosed with at least two months of diet treatment, or in current oha (oral hypoglycaemic agent) treatment with stable dose for at least six months
Beschreibung

Type 2 diabetes and treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0011878
UMLS CUI [3]
C0359086
bmi (body mass index) between 24 and 35 kg/m^2 (both inclusive)
Beschreibung

BMI

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
fasting plasma glucose between 6 and 15 mmol/l (both inclusive)
Beschreibung

Fasting plasma glucose

Datentyp

boolean

Alias
UMLS CUI [1]
C0583513
anti-gad (glutamic acid decarboxylase) negative
Beschreibung

Anti-gad

Datentyp

boolean

Alias
UMLS CUI [1]
C1167898
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product or related products
Beschreibung

Allergy to trial product

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006
receipt of any investigational drug within three months prior to this trial
Beschreibung

Experimental drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0304229
recurrent severe hypoglycaemia as judged by the investigator
Beschreibung

Recurrent severe hypoglycaemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0342316
cardiac disease or any clinically significant abnormal ecg (electrocardiogram)
Beschreibung

Cardiac disease or ECG

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0013798
use of any drug (except oral hypoglycaemic agents (ohas)) which in the investigator's opinion could interfere
Beschreibung

Pharmacotherapy and drug interactions

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0687133
with the blood glucose level (i.e., insulin, systemic corticosteroids, thiazides)
Beschreibung

Medication interferring with blood glucose level

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392201
UMLS CUI [1,2]
C0013216
UMLS CUI [1,3]
C0687133
liver or renal disease
Beschreibung

Liver or renal disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658

Ähnliche Modelle

Eligibility Diabetes NCT01507311

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01507311
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes and treatment
Item
diagnosed with type 2 diabetes, either newly diagnosed with at least two months of diet treatment, or in current oha (oral hypoglycaemic agent) treatment with stable dose for at least six months
boolean
C0011860 (UMLS CUI [1])
C0011878 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
BMI
Item
bmi (body mass index) between 24 and 35 kg/m^2 (both inclusive)
boolean
C1305855 (UMLS CUI [1])
Fasting plasma glucose
Item
fasting plasma glucose between 6 and 15 mmol/l (both inclusive)
boolean
C0583513 (UMLS CUI [1])
Anti-gad
Item
anti-gad (glutamic acid decarboxylase) negative
boolean
C1167898 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Experimental drugs
Item
receipt of any investigational drug within three months prior to this trial
boolean
C0304229 (UMLS CUI [1])
Recurrent severe hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
Cardiac disease or ECG
Item
cardiac disease or any clinically significant abnormal ecg (electrocardiogram)
boolean
C0018799 (UMLS CUI [1])
C0013798 (UMLS CUI [2])
Pharmacotherapy and drug interactions
Item
use of any drug (except oral hypoglycaemic agents (ohas)) which in the investigator's opinion could interfere
boolean
C0013216 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
Medication interferring with blood glucose level
Item
with the blood glucose level (i.e., insulin, systemic corticosteroids, thiazides)
boolean
C0392201 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0687133 (UMLS CUI [1,3])
Liver or renal disease
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video